The company's purpose is to provide fixation solutions for spinal implants. It also aims to develop, manufacture and market advanced medical devices and technologies that improve the stability, alignment and overall outcome of spinal surgeries. The company may establish branches and subsidiaries in Switzerland and/or abroad and participate in other companies in Switzerland and/or abroad, acquire, hold, encumber and sell real estate and intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial or other business activities that are directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, on a paid or unpaid basis, and provide collateral of all kinds for the liabilities of such persons or group companies, including guarantees, pledges and fiduciary transfers of the company's assets. In addition, it may engage in liquidity balancing/net liquidity centralization (cash pooling), including periodic balance adjustments (balancing), with group companies, without consideration, on preferential terms, interest-free, excluding the company's intention to make a profit, and assuming cluster risks.